scispace - formally typeset
Open AccessBook

Manual of hypertension

TLDR
The author examines the changing aspects of hypertension in children and adolescents, the impact of guidelines in the clinical practice, and treatment strategies selecting the proper Weber therapeutic agent.
Abstract
Introduction: How to use this book The Editor Section 1. Epidemiology Julius 1.1 Hypertension as a cardiovascular risk factor Dr W Kannel 1.2 Results of intervention trials Professor R Fagard Section 2. Etiology and Pathophysiology Julius 2.1 The animal modes of hypertension Professor A Ferrari 2.2 Hypertension as a genetic disease Professor P Hamet 2.3 Salt and other dietary factors Dr I Puddey 2.4 The renin-angiotension system Professor M Nicholls 2.5 Neural factors Professor M Esler 2.6 Hormones and other humoral factors Dr O Carretero 2.7 Cell membrane abnormalities Dr A Semplicini Section 3. Blood pressure measurement Mancia 3.1 Office assessment of blood pressure Dr M Weber 3.2 Home blood pressure Professor J Mallion 3.3 Ambulatory blood pressure Dr G Parati 3.4 Special blood pressure measuring devices Professor E OBrien Section 4. Specific (secondary) causes of hypertension Saruta 4.1 Renovascular hypertension Professor J Pohl 4.2 Renal parenchymal hypertension Professor M Epstein 4.3 Phaeocromocytoma Dr G Grassi 4.4 Cortico-adrenal hypertension Professor J Whitworth 4.5 Rare forms of secondary hypertension Professor R Gordon 4.6 Hypertension from exogenous substances Dr Y Saruta Section 5. Essential hypertension Weber 5.1 Diagnosing essential hypertension 5.2 Excluding secondary causes of hypertension Dr A Morganti 5.3 Routine assessment of end-organ damage Dr L Hansson 5.4 Special measurer of end-organ damage Dr T Pickering Section 6. Antihypertensive drugs Chalmers 6.1 Diuretics 6.2 Beta-blockers Dr B Prichard 6.3 Calcium antagonists Professor F Meredith 6.4 ACE inhibitors Professor D Clement 6.5 Alpha-blockers Dr H Elliot 6.6 Angiotensin II receptor antagonists Dr J Reid 6.7 Central agents Professor P van Zweiten 6.8 Other drugs Professor A Pessina Section 7. Treatment strategies selecting the proper Weber therapeutic agent 7.1 Goal blood pressure Professor A Zanchetti 7.2 Life-style changes Dr L Beilin 7.3 The step-care approach Dr B Materson 7.4 The substitution and other approaches Professor P de Leeuw 7.5 The pros and cons of fixed combinations 7.6 The problem of compliance to treatment Dr B Waeber Section 8. Treatment in special conditions Ferrari 8.1 Hypertension in children and adolescents Dr B Falkner 8.2 Hypertension in the elderly Professor F Messerli 8.3 Hypertension in blacks Dr K Jamerson 8.4 The patients with multiple risk factors Dr G Jennings 8.5 The diabetic hypertension patient 8.6 Hypertension in pregnancy Dr M Brown 8.7 Hypertension in transplant patients Dr A Mimran 8.8 Resistant hypertension Dr K Rahn Section 9 Changing aspects of hypertension Chalmers 9.1 Malignant hypertension Dr Y Seedat 9.2 Impact of guidelines in the clinical practice Professor J Chalmers 9.3 Failure of antihypertensive treatment in the population Dr S Oparil Assessment of cost-benefit of antihypertensive Prof E Ambrosioni treatment 9.5 Isolated office hypertension Professor G Mancia

read more

Citations
More filters
Journal ArticleDOI

A randomised trial of a 5 week, manual based, self-management programme for hypertension delivered in a cardiac patient club in Shanghai.

TL;DR: Patients with mild-to-moderate primary hypertension attending a 5 week, group and manual based, cognitive-behavioural self-management programme, delivered through a voluntary club in Shanghai experienced a significant reduction in blood pressure.

Fisiopatología de la hipertensión arterial esencial

TL;DR: In fact, La hipertension arterial es altamente prevalente en la sociedad mo-derna y no obstante los notables avances en el conocimiento de susmecanismos, el impac...

Cardiovascular regulation and vascular structure in prehypertension and coronary heart disease

Anna Myredal
TL;DR: Subjects with prehypertension show increased lability of myocardial repolarization, impaired baroreflex function and increased intimal wall thickness, which may contribute to the increased risk for cardiovascular mortality and morbidity previously reported in the studied populations.

Sex-specific analysis of left ventricular geometry in a population study in tallinn

TL;DR: The prevalence of eccentric hypertrophy in men increased with hypertension and obesity and the prevalence of concentric remodelling in men was not related to body mass index; it was significantly more often found in hypertensives.